76
Participants
Start Date
May 31, 2008
Primary Completion Date
August 31, 2010
Study Completion Date
December 31, 2011
capecitabine
Capecitabine is given orally at 1000mg/m\^2 twice a day for 14 days followed by 7 days of drug free period.
oxaliplatin
Oxaliplatin is given 110mg/m\^2 through a vein on day 1 every 21 days. Each 21 day cycle is repeated until progression of disease or unacceptable toxicity is observed.
sunitinib malate
sunitinib is given orally 25mg/day for 14 days followed by 7 days of drug free period.
capecitabine
Capecitabine is given orally at 1000mg/m\^2 twice a day for 14 days followed by 7 days of drug free period.
cisplatin
Cisplatin is given 80mg/m\^2 through a vein on day 1 every 21 days. Each 21 day cycle is repeated until progression of disease or unacceptable toxicity is observed.
sunitinib malate
sunitinib is given orally 25mg/day for 14 days followed by 7 days of drug free period.
Pfizer Investigational Site, Goyang-si
Pfizer Investigational Site, Seongnam-si
Pfizer Investigational Site, Seoul
Lead Sponsor
Pfizer
INDUSTRY